As of May 2026 Apellis Pharmaceuticals has a market cap of NZ$8.97 Billion. This makes Apellis Pharmaceuticals the world's 3071th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.